Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Fulgent Genetics, Inc. and its officers or directors [1]. Group 1: Investigation Details - The investigation is initiated on behalf of investors of Fulgent Genetics, Inc. [1]. - Investors are encouraged to contact Pomerantz LLP for more information regarding the investigation [1]. Group 2: Recent Developments - On February 28, 2025, Fulgent disclosed a civil investigative demand from the U.S. Department of Justice concerning potential false claims under the Uninsured Program [3]. - Following this disclosure, Fulgent's stock price decreased by $0.41 per share, representing a 2.61% decline, closing at $15.28 per share on March 3, 2025 [3].

INBS to participate with U.S. distribution partner SMARTOX at RISE25, the leading U.S. conference on addiction, mental health, and justice innovation which draws over 7,000 attendees annually With over 450 active accounts across 24 countries, INBS continues to meet growing global demand for reliable, on-site drug testing solutions across the workplace, treatment, and justice sectors NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical ...

Keysight Technologies Inc. (KEYS) reported solid second-quarter fiscal 2025 results, with both bottom and top lines beating the respective Zacks Consensus Estimate. Based in Santa Rosa, CA, the leading electronic design and testing solution provider reported higher year-over-year revenues, backed by strength in the AI data-center market, aerospace, defense and government end markets. Management’s focus on expanding its business through collaborations with established sector players is another positive.Net I ...

《商道创投网》创业家会员·本轮融资用途是什么？ 鹏武电子CEO谷陈鹏表示："本轮融资将主要用于新产品研发和规模化产能布局。我们将加大研发投入，进一步提升产品的性能和可靠性，满足市场对高端 集成电路测试设备的需求。同时，通过优化产能布局，提高生产效率，确保产品能够快速交付，为客户提供更优质的服务。这将有助于我们加速实现集成电 路测试设备的自主创新与国产化替代，推动国内集成电路产业的发展。 《商道创投网》创投家会员·本轮投资原因是什么？ 《商道创投网》2025年5月21日从官方获悉：上海鹏武电子科技有限公司（以下简称"鹏武电子"）近日完成了由金雨茂物领投的数千万A+轮融资。 《商道创投网》创业家会员·单位简介 鹏武电子成立于2015年，总部位于上海浦东新区，是一家专注于集成电路测试设备领域的高新技术企业。公司在上海张江设有销售中心，在苏州工业园区设 有研发中心，在浙江嘉兴设有制造基地。鹏武电子以客户需求为导向，结合硬件设计和软件开发，为客户提供一站式的集成电路晶圆和芯片测试验证设备及 解决方案。其产品在高速数字、高精度模拟和无线射频等领域具有显著的技术优势，能够有效降低检测成本、提高检测精度、保障产品质量，打破了 ...

Core Viewpoint - Pomerantz LLP is investigating potential securities fraud and unlawful business practices involving Fulgent Genetics, Inc. and its officers or directors [1][2] Group 1: Investigation Details - Pomerantz LLP is representing investors of Fulgent Genetics, Inc. in an investigation regarding claims of securities fraud [1] - The investigation follows a civil investigative demand received by Fulgent from the U.S. Department of Justice concerning potential false claims under the Uninsured Program [2] - Following the disclosure of the civil investigative demand, Fulgent's stock price decreased by $0.41 per share, or 2.61%, closing at $15.28 per share on March 3, 2025 [2] Group 2: Company Background - Pomerantz LLP is recognized as a leading firm in corporate, securities, and antitrust class litigation, with a history of over 85 years in the field [3] - The firm has a track record of recovering multimillion-dollar damages for victims of securities fraud and corporate misconduct [3]

Keysight Technologies, Inc. KEYS will release its second-quarter financial results after the closing bell on Tuesday, May 20.Analysts expect the Santa Rosa, California-based company to report quarterly earnings at $1.65 per share, up from $1.41 per share in the year-ago period. Keysight projects quarterly revenue of $1.28 billion, compared to $1.22 billion a year earlier, according to data from Benzinga Pro.On April 29, Keysight EDA and Intel Foundry announced a collaboration on EMIB-T Silicon Bridge Techno ...

Core Insights - AEM Holdings Ltd. collaborates with Intel Foundry to enhance access to System-Level Test (SLT) and Burn-In capabilities for advanced computing devices, aiming to accelerate time-to-market for fabless customers [1][2][5] Group 1: Collaboration Details - The partnership leverages decades of collaboration to create a mature SLT and Burn-In ecosystem, essential for high-performance computing (HPC) and artificial intelligence (AI) applications [1][2] - AEM provides device-specific configurable test units, advanced handlers, and software support, complementing Intel Foundry's services such as factory automation and test program development [3][9] Group 2: Customer Benefits - Key benefits for customers include enhanced test coverage, reduced capital expenditure, and faster time-to-market, supported by a scalable platform and local engineering teams [5][6][9] - The collaboration aims to meet rising performance demands and facilitate chiplet-based architectures, ensuring reliability for AI and HPC applications [5][6] Group 3: Company Overview - AEM Holdings Ltd. is a global leader in test innovation with a presence across Asia, Europe, and the United States, offering comprehensive semiconductor and electronics test solutions [7][8]

The assets of failed DNA testing firm 23andMe are being bought for $256 million. Biotechnology firm Regeneron Pharmaceuticals said on Monday it would acquire 23andMe's personal genome service, total health, and research services business lines, and its biobank of customers' genetic samples. Regeneron said San Francisco-headquartered 23andMe would continue to offer all consumer genome services. "We believe we can help 23andMe deliver and build upon its mission to help those interested in learning about th ...

Completion of 160 tests conducted in less than 90 minutes demonstrates a level of speed and efficiency beyond the limits of traditional testing approachesNEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the successful completion of a high-volume workforce drug test for Barcaldine Regional Council in remote Queensland, Australia, (the “ ...

DALLAS, May 16, 2025 (GLOBE NEWSWIRE) -- Psychemedics Corporation, the world’s leading provider of hair drug testing, is proud to announce it has been named “Most Innovative Drug Testing Company of the Year” by Acquisition International Magazine as part of its prestigious 2025 Global Excellence Awards. This recognition honors Psychemedics’ continued leadership in advancing the science of drug detection, including the recent launch of its Enhanced Quartile Reporting. This breakthrough analytics tool provides ...